Absci Corp. (ABSI)
8.84
-0.71
(-7.43%)
USD |
NASDAQ |
Aug 24, 16:00
8.96
+0.12
(+1.36%)
After-Hours: 07:58
Absci Enterprise Value : 1.319B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.319B |
| August 21, 2026 | 1.441B |
| August 20, 2026 | 1.395B |
| August 19, 2026 | 1.517B |
| August 18, 2026 | 1.321B |
| August 17, 2026 | 1.388B |
| August 14, 2026 | 1.378B |
| August 13, 2026 | 1.426B |
| August 12, 2026 | 1.432B |
| August 11, 2026 | 1.417B |
| August 10, 2026 | 1.348B |
| August 07, 2026 | 1.335B |
| August 06, 2026 | 1.227B |
| August 05, 2026 | 1.244B |
| August 04, 2026 | 1.258B |
| August 03, 2026 | 1.163B |
| July 31, 2026 | 1.137B |
| July 30, 2026 | 1.113B |
| July 29, 2026 | 986.44M |
| July 28, 2026 | 1.026B |
| July 27, 2026 | 1.100B |
| July 24, 2026 | 1.100B |
| July 23, 2026 | 1.187B |
| July 22, 2026 | 1.216B |
| July 21, 2026 | 1.230B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.203B |
| July 17, 2026 | 1.226B |
| July 16, 2026 | 1.215B |
| July 15, 2026 | 1.477B |
| July 14, 2026 | 1.558B |
| July 13, 2026 | 1.554B |
| July 10, 2026 | 1.621B |
| July 09, 2026 | 1.770B |
| July 08, 2026 | 1.707B |
| July 07, 2026 | 1.746B |
| July 06, 2026 | 1.782B |
| July 02, 2026 | 1.796B |
| July 01, 2026 | 1.709B |
| June 30, 2026 | 1.791B |
| June 29, 2026 | 1.642B |
| June 26, 2026 | 1.570B |
| June 25, 2026 | 1.465B |
| June 24, 2026 | 1.444B |
| June 23, 2026 | 1.030B |
| June 22, 2026 | 1.184B |
| June 18, 2026 | 1.030B |
| June 17, 2026 | 994.12M |
| June 16, 2026 | 966.16M |
| June 15, 2026 | 1.008B |
| June 12, 2026 | 935.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 8.751B |
| Prime Medicine, Inc. | 604.80M |
| Tenax Therapeutics, Inc. | -58.87M |
| Exicure, Inc. | 5.613M |
| Recursion Pharmaceuticals, Inc. | 1.251B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.21M |
| Revenue (Quarterly) | 0.318M |
| Total Expenses (Quarterly) | 33.53M |
| EPS Diluted (Quarterly) | -0.2109 |
| Gross Profit Margin (Quarterly) | -747.8% |
| Profit Margin (Quarterly) | -10.44K% |
| Earnings Yield | -9.05% |
| Normalized Earnings Yield | -9.322 |